# Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis

> **NCT03058068** · PHASE1 · WITHDRAWN · sponsor: **Joshua M Hare**

## Conditions studied

- Cystic Fibrosis

## Interventions

- **BIOLOGICAL:** Allo-hMSCs
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03058068
- **Lead sponsor:** Joshua M Hare
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12
- **Primary completion:** 2027-09
- **Final completion:** 2028-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left the institution
- **Last updated:** 2020-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03058068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03058068, "Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03058068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*